These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Antithymocyte globulin (ATG) and trenimon (TR): effects on T cells and graft rejection. Beatty JD; Friesen E; Linford JH; Israels LG Surg Forum; 1977; 28():327-9. PubMed ID: 364726 [No Abstract] [Full Text] [Related]
25. The anti-inflammatory effect of some immunosuppressive agents. Stevens JE; Willoughby DA J Pathol; 1969 Feb; 97(2):367-73. PubMed ID: 5352809 [No Abstract] [Full Text] [Related]
26. Pharmacological immunosuppressive agents. Salaman JR Ulster Med J; 1981; 50(Suppl 1):36-42. PubMed ID: 7015656 [No Abstract] [Full Text] [Related]
27. Suppression of the development of primary antibacterial immunity by heterologous anti-lymphocyte serum. Réthy L; Padányi M Acta Vet Acad Sci Hung; 1969; 19(4):405-15. PubMed ID: 4909689 [No Abstract] [Full Text] [Related]
29. Differential effect of immunosuppressive agents on T and B lymphocytes. Thomas F; Owens L; Thomas J; Wolf JS; Volk M; Mendez G; Lee HM Proc Clin Dial Transplant Forum; 1974; (4):124-9. PubMed ID: 4619655 [No Abstract] [Full Text] [Related]
30. Chemical-induced immunomodulation. Koller LD J Am Vet Med Assoc; 1982 Nov; 181(10):1102-6. PubMed ID: 6816774 [No Abstract] [Full Text] [Related]
31. [Genetic aspects of the action of immunosuppressive agents]. Pevnitskiĭ LA; Pisarev VM; Telegin LIu; Tutel'ian AV Vestn Ross Akad Med Nauk; 1992; (4):52-5. PubMed ID: 1384879 [TBL] [Abstract][Full Text] [Related]
32. [Pathways of the pharmacological regulation of immunoreceptor function]. Seĭfulla RD; Kim EK; Sentsova TB Farmakol Toksikol; 1979; 42(6):581-91. PubMed ID: 387439 [No Abstract] [Full Text] [Related]
33. Pathological effects and mode of action of antilymphocyte serum treatment. Turk JL Fed Proc; 1970; 29(1):136-41. PubMed ID: 4244017 [No Abstract] [Full Text] [Related]
34. [Immunosuppressive action of antithymocytic serum and specific antibodies on the formation of plaque- and rosette-forming cells]. Korshunov VM; Pinegin BV Patol Fiziol Eksp Ter; 1974; (1):53-7. PubMed ID: 4617852 [No Abstract] [Full Text] [Related]
35. Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man. Levey RH; Parkman R Transplant Proc; 1977 Mar; 9(1):1019-22. PubMed ID: 405764 [TBL] [Abstract][Full Text] [Related]
36. Immunopharmacology and its toxicological problems. Sterzl J Arch Toxicol Suppl; 1980; 4():109-19. PubMed ID: 6159870 [TBL] [Abstract][Full Text] [Related]
37. [Immunotherapy today]. D'Amelio R Riv Med Aeronaut Spaz; 1977; 40(1-2):123-52. PubMed ID: 311930 [No Abstract] [Full Text] [Related]
38. Immunosuppression, interferon, and viral infections. Glasgow LA Fed Proc; 1971; 30(6):1846-51. PubMed ID: 5001451 [No Abstract] [Full Text] [Related]
39. Immunosuppressive antithymus and antilymphocyte sera. I. Antisera to detergent-solubilized rat thymus antigens. Zimmerman B; Tsui F Transplantation; 1978 Nov; 26(5):361-4. PubMed ID: 309202 [No Abstract] [Full Text] [Related]
40. [Basis of immunosuppressive effect of D-penecillamine]. Schumacher K Internist (Berl); 1975 Oct; 16(10):460-5. PubMed ID: 1107252 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]